Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
19 Pt 1
pubmed:dateCreated
2005-10-5
pubmed:abstractText
Unfractionated heparin reduces metastasis in many murine models. Multiple mechanisms are proposed, particularly anticoagulation and/or inhibition of P-selectin and L-selectin. However, the doses used are not clinically tolerable and other heparins are now commonly used. We studied metastasis inhibition by clinically relevant levels of various heparins and investigated the structural basis for selectin inhibition differences.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/5-acetylneuraminyl-(2-3)-galactosyl-..., http://linkedlifedata.com/resource/pubmed/chemical/Anticoagulants, http://linkedlifedata.com/resource/pubmed/chemical/Disaccharides, http://linkedlifedata.com/resource/pubmed/chemical/Factor Xa, http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolytic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Heparin, http://linkedlifedata.com/resource/pubmed/chemical/Heparin, Low-Molecular-Weight, http://linkedlifedata.com/resource/pubmed/chemical/L-Selectin, http://linkedlifedata.com/resource/pubmed/chemical/Oligosaccharides, http://linkedlifedata.com/resource/pubmed/chemical/P-Selectin, http://linkedlifedata.com/resource/pubmed/chemical/Polysaccharides, http://linkedlifedata.com/resource/pubmed/chemical/Selectins, http://linkedlifedata.com/resource/pubmed/chemical/fondaparinux, http://linkedlifedata.com/resource/pubmed/chemical/tinzaparin
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
7003-11
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:16203794-Animals, pubmed-meshheading:16203794-Anticoagulants, pubmed-meshheading:16203794-Cell Line, Tumor, pubmed-meshheading:16203794-Disaccharides, pubmed-meshheading:16203794-Factor Xa, pubmed-meshheading:16203794-Fibrinolytic Agents, pubmed-meshheading:16203794-Heparin, pubmed-meshheading:16203794-Heparin, Low-Molecular-Weight, pubmed-meshheading:16203794-Kinetics, pubmed-meshheading:16203794-L-Selectin, pubmed-meshheading:16203794-Melanoma, pubmed-meshheading:16203794-Mice, pubmed-meshheading:16203794-Mice, Inbred C57BL, pubmed-meshheading:16203794-Neoplasm Metastasis, pubmed-meshheading:16203794-Oligosaccharides, pubmed-meshheading:16203794-P-Selectin, pubmed-meshheading:16203794-Polysaccharides, pubmed-meshheading:16203794-Protein Binding, pubmed-meshheading:16203794-Selectins, pubmed-meshheading:16203794-Temperature, pubmed-meshheading:16203794-Thrombosis, pubmed-meshheading:16203794-Time Factors
pubmed:year
2005
pubmed:articleTitle
Differential metastasis inhibition by clinically relevant levels of heparins--correlation with selectin inhibition, not antithrombotic activity.
pubmed:affiliation
Glycobiology Research and Training Center, Department of Medicine, Biomedical Sciences Graduate Program, University of California, San Diego, La Jolla, California 92093-0687, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, N.I.H., Extramural